Showing results (81-90 of 200) with videos related to
Sort By:
Pageof 20
Chemosphere|February 28, 2020
Inactivation of helminth eggs in an electro-Fenton reactor: Towards full electrochemical disinfection of human waste using activated carbonIrma Robles, Emmanuel Becerra, J A Barrios, et al.Clinical Colorectal Cancer|September 10, 2013
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumabJavier Sastre, Marta Vidaurreta, Auxiliadora Gómez, et al.Emergency Radiology|April 22, 2014
Diagnostic performance of CT esophagography in patients with suspected esophageal ruptureTatiana Suarez-Poveda, Carlos H Morales-Uribe, Alvaro Sanabria, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 18, 2024
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023)Fernando Rivera, Federico Longo, Marta Martín Richard, et al.ESMO Open|November 16, 2016
Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trialSalvatore Siena, Josep Tabernero, Gyorgy Bodoky, et al.The Oncologist|February 25, 2012
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group StudyJavier Sastre, Cristina Grávalos, Fernando Rivera, et al.Cureus|December 30, 2021
Physician-Perceived Barriers to Treating Opioid Use Disorder in the Emergency DepartmentGideon Logan, Amber Mirajkar, Jessica Houck, et al.Cancer Letters|June 20, 2014
A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyondCarlos Gomez-Martín, Fernando Lopez-Rios, Jorge Aparicio, et al.Journal of Gastrointestinal Cancer|February 25, 2015
Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)György Bodoky, Max E Scheulen, Fernando Rivera, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 29, 2022
SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)Ana Fernández-Montes, Julia Alcaide, María Alsina, et al.Pageof 20